Agonist activation of PPARα has been shown to protect against acute myocardial ischemia [46], myocardial remodeling and hypertension [47], hypertrophy [48], diabetic cardiomyopathy [49], atherogenesis [50] and vascular injury [44]. This evidence concerns the gene PPARA and Hypertension.